FI953001A - Insuliinianalogeja - Google Patents

Insuliinianalogeja Download PDF

Info

Publication number
FI953001A
FI953001A FI953001A FI953001A FI953001A FI 953001 A FI953001 A FI 953001A FI 953001 A FI953001 A FI 953001A FI 953001 A FI953001 A FI 953001A FI 953001 A FI953001 A FI 953001A
Authority
FI
Finland
Prior art keywords
insulin analogues
analogues
insulin
Prior art date
Application number
FI953001A
Other languages
English (en)
Swedish (sv)
Other versions
FI953001A0 (fi
Inventor
Ronald Eugene Change
Li Fan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI953001A publication Critical patent/FI953001A/fi
Publication of FI953001A0 publication Critical patent/FI953001A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FI953001A 1992-12-18 1995-06-16 Insuliinianalogeja FI953001A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99565992A 1992-12-18 1992-12-18
PCT/US1993/012237 WO1994014461A1 (en) 1992-12-18 1993-12-15 Insulin analogs

Publications (2)

Publication Number Publication Date
FI953001A true FI953001A (fi) 1995-06-16
FI953001A0 FI953001A0 (fi) 1995-06-16

Family

ID=25542078

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953001A FI953001A0 (fi) 1992-12-18 1995-06-16 Insuliinianalogeja

Country Status (14)

Country Link
EP (1) EP0605983A3 (fi)
JP (1) JPH08504820A (fi)
CN (1) CN1094059A (fi)
AU (1) AU680462B2 (fi)
BR (1) BR9307687A (fi)
CA (1) CA2151134A1 (fi)
CZ (1) CZ158895A3 (fi)
FI (1) FI953001A0 (fi)
HU (1) HUT71583A (fi)
MX (1) MX9307991A (fi)
NO (1) NO952336D0 (fi)
PL (1) PL310007A1 (fi)
WO (1) WO1994014461A1 (fi)
ZA (1) ZA939477B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559094A (en) * 1994-08-02 1996-09-24 Eli Lilly And Company AspB1 insulin analogs
CN1125081C (zh) * 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
WO2010043566A2 (de) 2008-10-17 2010-04-22 Sanofi-Aventis Deutschland Gmbh Kombination von einem insulin und einem glp-1-agonisten
US9707176B2 (en) 2009-11-13 2017-07-18 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist and methionine
ES2855146T3 (es) 2009-11-13 2021-09-23 Sanofi Aventis Deutschland Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PT2750699E (pt) 2011-08-29 2015-11-03 Sanofi Aventis Deutschland Acelerómetro pendular
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
AU2013323669B2 (en) 2012-09-26 2018-03-01 Indiana University Research And Technology Corporation Insulin analog dimers
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
IL102240A0 (en) * 1991-06-21 1993-01-14 Lilly Co Eli Insulin analogs

Also Published As

Publication number Publication date
BR9307687A (pt) 2002-02-19
NO952336L (no) 1995-06-13
NO952336D0 (no) 1995-06-13
AU680462B2 (en) 1997-07-31
CZ158895A3 (en) 1995-12-13
AU5827994A (en) 1994-07-19
ZA939477B (en) 1995-06-19
JPH08504820A (ja) 1996-05-28
EP0605983A3 (en) 1995-06-07
WO1994014461A1 (en) 1994-07-07
CN1094059A (zh) 1994-10-26
EP0605983A2 (en) 1994-07-13
HUT71583A (en) 1995-12-28
MX9307991A (es) 1994-08-31
FI953001A0 (fi) 1995-06-16
CA2151134A1 (en) 1994-07-07
PL310007A1 (en) 1995-11-13
HU9501762D0 (en) 1995-08-28

Similar Documents

Publication Publication Date Title
BR9305077A (pt) Seringa hipodémica
DE9311907U1 (de) Spritze
ATE237635T1 (de) Acylierte insulinanalogen
FI956308A0 (fi) Injektioruisku
DK186089A (da) Sproejter
DE69222622D1 (de) Spritze
FI933933A0 (fi) Ampull
BR9306974A (pt) Seringa
FI953001A (fi) Insuliinianalogeja
DE59308356D1 (de) Spritze
FI943581A (fi) Ruisku
DE69304645D1 (de) Kanuele
DE69309570D1 (de) Spritze
NO922376D0 (no) Insulinanaloger
KR920021041U (ko) 세척기
NO950721D0 (no) Insulinanaloger
NO942783D0 (no) Spröyte
KR940001042U (ko) 앰플(Ampoule)
KR950008187U (ko) 화살식 동물 주사기
BR9200932A (pt) Seringa
KR930017636U (ko) 세척기
SE9202756D0 (sv) Spruta
DE9206878U1 (de) Spritze
DK265590A (da) Insulinanaloger
ATE100824T1 (de) Insulin-analoge.

Legal Events

Date Code Title Description
FD Application lapsed